Osia 2 Pediatric Expansion Study

Status Completed

Clinical Trial Summary

Clinical Trial Description

The CochlearTM Osia®2 System was cleared by the Food and Drug Administration November 15, 2019 (K191921) for individuals aged 12 years and older who present with conductive or mixed hearing loss (up to 55 dB HL) or single-sided-deafness (SSD). Published and unpublished data suggest significant pre to postoperative benefit and minimal risk in both children and adults who have received the Osia system. Due to the success of the Osia 2 system in the United States within the currently indicated patient population, clinical providers have since requested the ability to use the Osia 2 system in children aged 11 years and younger who meet the audiometric requirements. As the Osia 2 system is based on existing bone conduction and cochlear implant technologies which each possess a younger age of implantation requirement (5 years for bone conduction and 9 months for cochlear implantation), the current proposal is to align the age at implantation requirement with existing surgical bone conduction technology such as the Baha Connect and Baha Attract Systems to 5 years of age. Therefore, the objective of this study is to examine the safety and effectiveness of the Cochlear Osia 2 system in a group of pediatric subjects aged 5 to 11 years who suffer from conductive or mixed hearing loss (up to 55 dB HL), or single-sided-deafness (SSD) with the intent of expanding the indications for use. ;

Study Design

Related Conditions & MeSH terms

Conductive Hearing Loss
Deafness
Hearing Loss
Hearing Loss, Conductive
Hearing Loss, Mixed Conductive-Sensorineural
Mixed Hearing Loss
Single-Sided Deafness

Clinical Trial Details

NCT number	NCT05000931
Study type	Interventional
Source	Cochlear
Contact
Status	Completed
Phase	N/A
Start date	January 26, 2022
Completion date	March 14, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03723161` - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed	`NCT04320407` - Osia CPT Code Study	N/A
Active, not recruiting	`NCT01445977` - SoundBite Hearing System Long Term Multi Site Patient Use Study	N/A
Completed	`NCT02304692` - Clinical Survey of Different Abutment Topologies	N/A
Recruiting	`NCT00393159` - The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children	Phase 4
Recruiting	`NCT06164184` - Interest of the Cone Beam Scanner of Temporal Bones in the Analysis of Conductive Hearing Loss
Not yet recruiting	`NCT01967498` - Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study	N/A
Active, not recruiting	`NCT05628285` - Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear	N/A
Completed	`NCT03374787` - Evaluation of Sound Processor for a Transcutaneous System	N/A
Completed	`NCT02092610` - Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System	N/A
Completed	`NCT01671176` - Wide Diameter Bone Anchored Implant Study	N/A
Completed	`NCT03086135` - Clinical Performance of a New Implant System for Bone Conduction Hearing	N/A
Recruiting	`NCT01807559` - SoundBite Hearing System 24 Month Multi Site Patient Use Study	N/A
Withdrawn	`NCT01264510` - Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)	Phase 4
Recruiting	`NCT04803279` - Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Completed	`NCT03143257` - Ambispective Clinical Evaluation of Sophono™
Completed	`NCT02274129` - Clinical Survey of Oticon Medical Healing Cap	N/A
Withdrawn	`NCT03541967` - Comparison of a New Bone Conduction Hearing System to a Osteo-integrated Bone Conduction Hearing Aid on a Softband	N/A
Recruiting	`NCT03327194` - Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss	N/A
Completed	`NCT03746548` - Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.